| Financial Year |
March 31 2023 |
| Monetary Funds |
10,946,367.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
5,955,644.56 |
| Advances to Suppliers |
4,824,915.00 |
| Other Receivables |
31,296,736.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
169,383,849.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,019,081.96 |
| Total Current Assets |
223,426,594.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
90,621,199.78 |
| Under-construction Projects |
25,204.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
11,338,037.18 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,971,807.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,692,848.50 |
| Deferred Income Tax Assets |
314,690.77 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
257,668,708.58 |
| Total Assets |
481,095,303.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
73,639,681.38 |
| Accounts Received In Advance |
932,554.40 |
| Employee Compensation Payable |
14,048,432.34 |
| Taxes Payable |
62,895,377.74 |
| Interest Payable |
4,108,786.72 |
| Dividend Payable |
-- |
| Other payables |
119,109,107.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
737,334.90 |
| Other Current Liabilities |
283,542.83 |
| Sub-Total of Current Liabilities |
274,382,022.84 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,754,546.20 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,526,907.41 |
| Total Liabilities |
342,908,930.25 |
| Paid-In Capital(Or Share Stock) |
177,408,000.00 |
| Capital Surplus |
553,481,876.67 |
| Surplus Reserve |
5,861,319.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-600,084,269.38 |
| Minority Stockholder's Interest |
1,519,445.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
136,666,927.27 |
| Owner's Equity（Stockholder's Equity） |
138,186,372.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
481,095,303.03 |
